abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Divulgación

15 Abr 2022

Autor:
AbbVie

AbbVie statement

15 April 2022

...Hope all is well and apologies for the delay in getting back to you. For your questions regarding Ukraine, we would direct you to our company webpage that speaks to this issue – please see here: https://www.abbvie.com/ukraine.html

We will be sure to keep you updated and please let me know if you need anything further.

Thank you for reaching out and apologies again for the delay...

20 April 2022

As a follow up, I wanted to pass along the news we made yesterday that AbbVie will donate profits from Russia to humanitarian relief efforts in Ukraine. Please see below for our statement from yesterday:

AbbVie Will Donate Profits from Russia to Humanitarian Relief Efforts

We are committed to doing everything possible to support the people of Ukraine and those impacted across the region. Our primary focus continues to be the safety of our colleagues and ensuring patients have access to the medicines they need.

As a company dedicated to the health of patients, we will continue to supply our essential life-saving medicines in Russia. Today, we are announcing that all profits from sales of AbbVie’s essential medicines in Russia will be donated to support direct humanitarian relief efforts in Ukraine.

In addition, we previously announced the suspension of all sales and distribution of our aesthetics products in Russia. We have also halted new clinical studies and ceased enrollment of ongoing studies in Ukraine and Russia.

Our work with nonprofit partners and employees to support humanitarian relief efforts in Ukraine will continue as we hope for a peaceful resolution.

For more information on our full response, visit https://www.abbvie.com/ukraine.html.

Línea del tiempo

Información de privacidad

Este sitio usa cookies y otras tecnologías de almacenamiento web. Puede configurar sus preferencias de privacidad más adelante. Los cambios se aplicarán de inmediato.

Para más información sobre el uso que hacemos del almacenamiento web, por favor consulte nuestra Política de Cookies y Uso de Datos

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Cookies analíticas

ON
OFF

Cuando accede a nuestro sitio web, utilizamos Google Analytics para recopilar información sobre su visita. La aceptación de esta cookie nos permitirá conocer más detalles sobre su visita y mejorar la forma en que mostramos la información. Toda la información analítica es anónima y no la utilizamos para identificarle. Google proporciona un complemento de inhabilitación de Google Analytics para todos los navegadores populares.

Cookies promocionales

ON
OFF

Compartimos noticias y actualizaciones sobre empresas y derechos humanos a través de plataformas de terceros, incluidas las redes sociales y los motores de búsqueda. Estas cookies nos ayudan a comprender el rendimiento de estas promociones.

Sus preferencias de privacidad en este sitio

Este sitio usa cookies y otras tecnologías de almacenamiento web para mejorar su experiencia, mas allá de la funcionalidad básica necesaria.